INSYS Reports Third Quarter 2016 Results

Published: Nov 03, 2016

PHOENIX, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") today announced financial results for the three-month period ended September 30, 2016.

Highlights of and subsequent to the third quarter of 2016 include:

* Total net revenue was $55.2 million, compared to $91.3 million for the third quarter of 2015;

* Net income totaled $190,000, or $0.00 per basic and $0.00 per diluted share, compared to net income of $26.1 million, or $0.36 per basic and $0.34 per diluted share, for the third quarter of 2015;

Back to news